Sleep Optimization
Sleep is the most upstream lever for almost every concern peptide users come in with — energy, cognition, recovery, mood, body composition, immune function all run downstream of sleep. The peptide-side evidence for sleep, however, is the weakest in the Juno catalog. Most of it comes from Russian and Soviet research that Western clinical trials have not replicated. Be honest with yourself about that before starting.
This protocol assumes you have already addressed sleep hygiene. Consistent sleep-wake times, screens off 60 minutes before bed, room temperature ≤68°F, no caffeine after noon, no alcohol within 3 hours of bed. If any of those are not in place, fix them before adding peptides — those interventions have stronger evidence than anything in this protocol, cost nothing, and are reversible.
If sleep hygiene is dialed in and you still have persistent sleep-quality issues (long sleep latency, frequent waking, non-restorative sleep, declining REM/deep-sleep on your tracker), this is the peptide-specific path most community users work through. Phase 1 cycles epithalon as the foundation; Phase 2 adds DSIP for sleep architecture if Phase 1 alone is insufficient.
Phases
Phase 1 — Foundation (epithalon cycle)
weeks 1-8Epithalon at 5mg SubQ nightly for a 30-60 day cycle, then OFF for 4-6 months before the next cycle. Original Khavinson protocols used shorter 5-day-on / 25-day-off courses run 1-2× per year; modern community practice extends the on-period for sustained telomerase induction. No strong head-to-head evidence either schedule is superior — see the epithalon peptide page for the full cycle breakdown.
- Epithalon5 mg · daily · evening
5mg SubQ nightly during the 30-60 day on-cycle. Evening timing aligns with the peptide's pineal-axis mechanism (melatonin signaling restoration).
What “working” looks like
Sleep latency reduces by 10-20 minutes within 2-3 weeks. Fewer mid-night wakings. Improvement in subjective restorative quality + (if tracking) increased REM and deep-sleep percentages on your sleep tracker.
Decision criteria
If working by week 4: complete the full 30-60 day cycle. Then OFF for 4-6 months before considering another cycle — over-running epithalon without an off-period defeats the cycling discipline and has uncharacterized long-term effects. If NOT working by week 4: don't escalate dose. Reassess sleep hygiene and rule out sleep apnea (see Cautions) before moving to Phase 2.
Labs to pull
- Sleep study (polysomnography) if snoring + daytime sleepiness — rule out apnea before assuming peptides will help
- TSH + free T3 — undiagnosed hypothyroidism mimics non-restorative sleep
- Ferritin — low iron disrupts sleep architecture
Phase 2 — Add sleep-architecture layer (DSIP)
weeks 8+Add DSIP only if Phase 1 alone is insufficient. DSIP (Delta Sleep Inducing Peptide) targets sleep architecture directly — slow-wave (deep) sleep promotion. 100mcg SubQ 30-60 minutes before bed. Layer DURING the epithalon cycle for additive effect, or use solo during the epithalon off-period if you want continued support without re-cycling.
- Epithalon5 mg · daily · evening
Continue Phase 1 cycle through its full 30-60 day duration. Once the on-cycle ends, stop epithalon and continue with DSIP only until the next cycle 4-6 months later.
- DSIP100 mcg · daily · evening
100mcg SubQ 30-60 minutes before bed. Mechanism is direct (slow-wave sleep promotion) rather than circadian (epithalon's pineal axis), so the two work on different layers.
What “working” looks like
Deeper sleep on your tracker (increased deep-sleep percentage). Waking up feeling more rested even with the same total sleep hours. Reduced reliance on caffeine for daytime alertness.
Decision criteria
If working at week 12: continue through the end of the epithalon on-cycle, then drop to DSIP-only during the off-period. If not working at week 12: discontinue DSIP. The combined regimen isn't right for you — either the bottleneck isn't sleep-architecture (revisit sleep hygiene, sleep study, thyroid) or the peptide doesn't work in your physiology.
Cautions
- Sleep apnea is the single most common cause of non-restorative sleep and peptides do not fix mechanical breathing disruption. If you snore loudly, wake up gasping, or have a partner-reported apnea concern, get a sleep study BEFORE starting this protocol. CPAP fixes the problem; peptides will only ever mask it.
- SSRI / MAOI / sedative interactions: melatonergic peptides (especially epithalon) interact with the same systems SSRIs, MAOIs, and benzodiazepine-class sedatives target. Combining without clinical oversight can produce additive sedation, blunt the antidepressant effect, or unpredictably modulate REM sleep. If you are on any of these medications, discuss with the prescribing clinician before starting.
- Pediatric pineal-axis disclaimer: the pineal gland is still maturing through adolescence and modulating its signaling with exogenous peptides during this window has uncharacterized long-term effects. This protocol is for adults 18+ only.
- Daytime sedation is the most common acute side-effect when dose timing is wrong. Epithalon and DSIP should both be given in the evening (90+ minutes before bed for epithalon; 30-60 minutes before bed for DSIP). Morning or midday dosing produces drowsiness without the sleep benefit.
- Cycling discipline matters. Epithalon's evidence base assumes cycling with proper off-periods (4-6 months between cycles in modern practice, 6 months in original Khavinson protocols). Running epithalon continuously without an off-period defeats the cycling rationale and has uncharacterized long-term implications.
Discuss with your clinician
- If you have ANY sleep-disordered-breathing symptoms (loud snoring, partner-witnessed apnea, daytime sleepiness, morning headaches), get a sleep study before starting this protocol — peptides are not the right tool here.
- If you are on SSRIs, MAOIs, benzodiazepines, zolpidem, or any other psychiatric/sedative medication, ask the prescribing clinician about interactions with melatonergic peptides before adding either.
- Get baseline labs before Phase 1: TSH + free T3 (rule out hypothyroidism), ferritin (low iron disrupts sleep architecture), and a complete metabolic panel.
- Discuss the cycle plan explicitly. Confirm with your clinician that you understand the 30-60 day on / 4-6 month off cadence and have a calendar reminder set for both phases.
- If you have a history of pineal-region pathology (rare — but pinealoma, pineal cysts on imaging) discuss with neurology before starting epithalon or any pineal-axis peptide.
Evidence summary
Tier 4 protocol overall — the most-disclaimed of any V1 Juno protocol. Epithalon (Phase 1) is Tier 4: most evidence is Russian/Soviet research from the Khavinson lab; Western clinical replication is essentially absent. DSIP (Phase 2) is Tier 3: sleep-architecture mechanism is mechanistically coherent but human-outcome trial evidence is thin. The mechanistic case for both is real; the human-evidence gap is wide. This protocol works for some users in community practice; it has not been validated by modern Western clinical trials.
Often combined with
- Energy & Vitality
Persistent low energy is often downstream of poor sleep. If you are working through the Energy protocol and Phase 1 (cofactor restoration) isn't moving the needle, fix sleep before assuming the bottleneck is mitochondrial — sleep is the more common upstream cause.
Ready to add this protocol to your stack?
Phase 1 entries start today; later phases are future-dated and ready to edit.